Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Recombinant Human P Cadherin Protein (6×His Tag) (AC1014)
Cat.#: ACPP-1014
Specifications
Despition Recombinant Human P Cadherin Protein (6×His Tag) for SDS-PAGE SIZE 50 µg Source Recombinant Protein Length Fragment Expression System HEK293 cells Protein Species Human Sequence CDH3 (Ser18-Gly654) + 6×His Tag Molecular Weight 60.9 kDa without signal peptide Purity > 95% by SDS-PAGE and Coomassie blue staining. Form Lyophilized Tag C-terminal 6×His Tag Applications SDS-PAGE Storage Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1219 Prominin 1 Blocking Peptide (AC1219) 250 µg inquiry ACPP-1258 Pannexin 1 Blocking Peptide (AC1258) 250 µg inquiry ACPP-1739 Human SYT3 Protein (AC1739) 5 µg inquiry ACPP-1513 Human FGFR2 Protein (AC1513) 2 µg inquiry ACPP-1121 Recombinant Human GFAP Protein (AC1121) 25 µl inquiry ACPP-1097 Synthetic Nanodisc Human ENTPD2 Protein (AC1097) 10 µg inquiry ACPP-1336 Estrogen Receptor alpha Blocking Peptide (AC1336) 250 µg inquiry ACPP-1160 Recombinant Human GPCR GPR20 Protein (Fc Tag) (AC1160) 50 µg inquiry ACPP-1134 Recombinant Mouse ROR1 Protein (6×His Tag) (AC1134) 50 µg inquiry ACPP-1030 Recombinant Human Acetylcholinesterase Protein (6×His Tag) (AC1030) 50 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket